Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence SEAEDASLLSFMQGYMKHATKTA
Primary information
sequence IDSeq_6961
Peptide sequenceSEAEDASLLSFMQGYMKHATKTA
CancerPDF_ID CancerPDF_ID1755, CancerPDF_ID1762, CancerPDF_ID2988,
PMID21136997,21136997,21136997
Protein NameApolipoprotein C-III precursor (Apo-CIII),Apolipoprotein C-III precursor (Apo-CIII),Apolipoprotein C-III
UniprotKB Entry NameAPOC3_HUMAN,APOC3_HUMAN,APOC3_HUMAN
FluidSerum,Serum,Plasma
M/Z2515.17231,2531.16722,2515.1723
Charge1,1,1
Mass (in Da)NA,NA,NA
fdrNA,NA,NA
Profiling TechniqueLC-MS,LC-MS,LC-MS
Peptide Identification techniqueLC-MS-MS/MS,LC-MS-MS/MS,LC-MS-MS/MS
Quantification TechniqueLC-ESI-MS,LC-ESI-MS,LC-ESI-MS
Labelled/Label FreeLabel Free,Label Free,Label Free
FDRNA,NA,NA
CancerPDF_ID CancerPDF_ID1755, CancerPDF_ID1762, CancerPDF_ID2988,
p-ValueNA,NA,NA
SoftwareMASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT(v. 2.2.01)
Length23,23,23
Cancer TypeColorectal cancer,Colorectal cancer,Normal
DatabaseSwissProt Database,SwissProt Database,SwissProt Database
ModificationNA,Oxidation of Met,NA
Number of Patients30 patients and 30 healthy controls,30 patients and 30 healthy controls,27 healthy individuals
RegulationNA,NA,NA
ValidationLeave One out Cross validation,Leave One out Cross validation,Leave One out Cross validation
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasNA
IEDB